Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
Article Details
- CitationCopy to clipboard
Rodriguez-Moran M, Guerrero-Romero F
Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
Diabetes Care. 2003 Apr;26(4):1147-52.
- PubMed ID
- 12663588 [ View in PubMed]
- Abstract
OBJECTIVE: To determine whether oral magnesium supplementation (as magnesium chloride [MgCl(2)] solution) improves both insulin sensitivity and metabolic control in type 2 diabetic subjects with decreased serum magnesium levels. RESEARCH DESIGN AND METHODS: This study was a clinical randomized double-blind placebo-controlled trial. A total of 63 subjects with type 2 diabetes and decreased serum magnesium (serum magnesium levels
DrugBank Data that Cites this Article
- Drugs